• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In regard to Brown et al.剂量递增而非“新生物学原理”可解释立体定向体部放射治疗非小细胞肺癌的疗效。关于布朗等人的研究。
Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):692-3. doi: 10.1016/j.ijrobp.2014.03.027.
2
Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In reply to Rao et al.剂量递增而非“新生物学原理”可解释立体定向体部放射治疗非小细胞肺癌的疗效。回应饶等人的文章
Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):693-4. doi: 10.1016/j.ijrobp.2014.03.014.
3
Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer.剂量递增而非“新生物学机制”能够解释立体定向体部放射治疗对非小细胞肺癌的疗效。
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1159-60. doi: 10.1016/j.ijrobp.2012.11.003.
4
Stereotactic ablative radiation therapy for centrally located recurrences of non-small cell lung cancer: in regard to Chang et al.立体定向消融放疗用于治疗中央型非小细胞肺癌复发：关于Chang等人的研究
Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1141-1142. doi: 10.1016/j.ijrobp.2014.04.037. Epub 2014 Jul 8.
5
Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes.立体定向体部放射治疗作为立体定向放射外科的衍生物：临床独立但有持久的共同主题。
J Clin Oncol. 2014 Sep 10;32(26):2827-31. doi: 10.1200/JCO.2014.56.7362. Epub 2014 Aug 11.
6
[Stereotactic body radiation therapy for early non-small cell lung cancer].早期非小细胞肺癌的立体定向体部放射治疗
Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):561-3.
7
Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.立体定向体部放射治疗用于I期非小细胞肺癌
Thorac Surg Clin. 2016 Aug;26(3):261-9. doi: 10.1016/j.thorsurg.2016.04.008.
8
Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer.立体定向放射治疗：改变 I 期非小细胞肺癌的治疗模式。
Curr Opin Oncol. 2011 Mar;23(2):133-9. doi: 10.1097/CCO.0b013e328341ee11.
9
Stereotactic body radiation therapy for inoperable lung cancer.立体定向体部放射治疗不可切除的肺癌。
JAMA. 2010 Jun 16;303(23):2354-5; author reply 2355. doi: 10.1001/jama.2010.777.
10
Pattern of failure following chemoradiation for locally advanced non-small cell lung cancer: potential role for stereotactic body radiotherapy.局部晚期非小细胞肺癌放化疗后失败模式：立体定向体部放疗的潜在作用。
Anticancer Res. 2010 Mar;30(3):953-61.

引用本文的文献

1
Simulating the Potential of Model-Based Individualized Prescriptions for Ultracentral Lung Tumors.模拟基于模型的超中心型肺肿瘤个体化处方的潜力。
Adv Radiat Oncol. 2023 Jun 5;8(6):101285. doi: 10.1016/j.adro.2023.101285. eCollection 2023 Nov-Dec.
2
Potential Clinical Significance of Overall Targeting Accuracy and Motion Management in the Treatment of Tumors That Move With Respiration: Lessons Learnt From a Quarter Century of Stereotactic Body Radiotherapy From Dose Response Models.整体靶向准确性和运动管理在呼吸运动肿瘤治疗中的潜在临床意义：从剂量反应模型的25年立体定向体部放射治疗中吸取的经验教训
Front Oncol. 2021 Feb 9;10:591430. doi: 10.3389/fonc.2020.591430. eCollection 2020.
3
Dose escalation in the definite target volume.在明确的靶区内增加剂量。
Med Phys. 2020 Jul;47(7):3174-3183. doi: 10.1002/mp.14164. Epub 2020 May 11.
4
Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules.为广泛的分割方案模拟肺癌对放射治疗的细胞反应。
Clin Cancer Res. 2017 Sep 15;23(18):5469-5479. doi: 10.1158/1078-0432.CCR-16-3277. Epub 2017 May 24.

本文引用的文献

1
Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control.立体定向体部放射治疗和三维适形放射治疗Ⅰ期非小细胞肺癌：生物等效剂量和局部控制的荟萃分析。
Pract Radiat Oncol. 2012 Oct-Dec;2(4):288-295. doi: 10.1016/j.prro.2011.10.004. Epub 2011 Dec 3.
2
The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?SRS 和 SBRT 的肿瘤放射生物学：涉及的不仅仅是 5 Rs 吗？
Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):254-62. doi: 10.1016/j.ijrobp.2013.07.022.
3
Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer.剂量递增而非“新生物学机制”能够解释立体定向体部放射治疗对非小细胞肺癌的疗效。
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1159-60. doi: 10.1016/j.ijrobp.2012.11.003.

Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In regard to Brown et al.

作者信息

Rao Shyam S, Oh Jung Hun, Jackson Andrew, Deasy Joseph O

机构信息

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.

Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York.

出版信息

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):692-3. doi: 10.1016/j.ijrobp.2014.03.027.

DOI:10.1016/j.ijrobp.2014.03.027
PMID:24929171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4822491/
Abstract
摘要